• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估澳大利亚治疗结果概况表在药物健康治疗人群中电话管理的有效性。

Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.

机构信息

Sydney School of Medicine (Central Clinical School), Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2020 Jul;39(5):441-446. doi: 10.1111/dar.13088. Epub 2020 May 12.

DOI:10.1111/dar.13088
PMID:32395850
Abstract

INTRODUCTION AND AIMS

The Australian Treatment Outcomes Profile (ATOP) is a brief clinical tool measuring recent substance use, health and wellbeing among clients attending alcohol and other drug (AOD) treatment services. It has previously been assessed for concurrent validity and inter-rater reliability. In this study we examine whether it is suitable for administration over the telephone.

DESIGN AND METHODS

We recruited a sample of 107 AOD clients across public sector specialist AOD treatment services in New South Wales, Australia between 2016 and 2018. Participants had a mean age of 47 years and 46% were female. Participants completed a face-to-face ATOP and a phone ATOP with a researcher within 5 days. Comparisons between the two administration modes were undertaken using Spearman's rank correlation coefficient for continuous or ordinal variables, and Cohen's Kappa for nominal variables.

RESULTS

Among 107 participants, 59% were attending for alcohol treatment and 41% for opioid treatment. Most ATOP items (76%) reached above 0.7 (good) or 0.9 (excellent) agreement between face-to-face and telephone use.

DISCUSSION AND CONCLUSIONS

Our findings suggest that the ATOP is a suitable instrument for telephone monitoring of recent substance use, health and social functioning among AOD clients. Its validation for remote use over the telephone will support staff to monitor clients' risks and outcomes-of particular relevance in response to the COVID-19 pandemic in which services are increasingly relying on telework approaches to client monitoring.

摘要

简介和目的

澳大利亚治疗结果概况(ATOP)是一种简短的临床工具,用于衡量接受酒精和其他药物(AOD)治疗服务的患者最近的物质使用、健康和幸福感。它之前已经过了同时效度和评分者间信度的评估。在这项研究中,我们研究了它是否适合通过电话进行管理。

设计和方法

我们于 2016 年至 2018 年期间在澳大利亚新南威尔士州的公共部门专科 AOD 治疗服务机构招募了 107 名 AOD 患者。参与者的平均年龄为 47 岁,46%为女性。参与者在 5 天内完成了面对面的 ATOP 和电话 ATOP 与研究人员。对于连续或有序变量,我们使用斯皮尔曼等级相关系数进行两种管理模式之间的比较,对于名义变量,我们使用 Cohen 的 Kappa。

结果

在 107 名参与者中,59%的人参加酒精治疗,41%的人参加阿片类药物治疗。大多数 ATOP 项目(76%)在面对面和电话使用之间达到了 0.7(良好)或 0.9(优秀)的一致性。

讨论和结论

我们的研究结果表明,ATOP 是一种适合电话监测 AOD 患者最近物质使用、健康和社会功能的工具。它在电话远程使用方面的验证将支持工作人员监测客户的风险和结果,特别是在 COVID-19 大流行期间,服务越来越依赖于远程监测客户的方法。

相似文献

1
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.评估澳大利亚治疗结果概况表在药物健康治疗人群中电话管理的有效性。
Drug Alcohol Rev. 2020 Jul;39(5):441-446. doi: 10.1111/dar.13088. Epub 2020 May 12.
2
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.评估澳大利亚治疗结果概况(ATOP)在酒精和阿片类药物治疗人群中的同时效度、评定者间信度和重测信度。
Addiction. 2021 May;116(5):1245-1255. doi: 10.1111/add.15331. Epub 2021 Jan 4.
3
The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.澳大利亚治疗结果概况工具作为老年酒精及其他药物使用者的临床工具:一项验证研究。
Drug Alcohol Rev. 2016 Nov;35(6):673-677. doi: 10.1111/dar.12393. Epub 2016 Apr 13.
4
Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings.验证和实施澳大利亚治疗成果简介在专科药物和酒精环境中。
Drug Alcohol Rev. 2014 Jan;33(1):33-42. doi: 10.1111/dar.12083. Epub 2013 Nov 11.
5
Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.利用澳大利亚治疗结果概况确定药物和酒精服务客户中具有临床意义变化的阈值。
Addiction. 2023 Dec;118(12):2457-2465. doi: 10.1111/add.16295. Epub 2023 Jul 8.
6
Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).阿片类维持药物治疗服务中用于常规结果监测的简短工具的开发与验证:简短治疗结果测量(BTOM)
Drug Alcohol Depend. 2005 Oct 1;80(1):125-33. doi: 10.1016/j.drugalcdep.2005.04.001.
7
Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.确定澳大利亚治疗结果概况中心理健康、身体健康和生活质量问题的临床临界分数。
Drug Alcohol Rev. 2022 Jan;41(1):106-113. doi: 10.1111/dar.13346. Epub 2021 Jun 29.
8
Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services.接受专业药物和酒精服务的老年客户的物质使用、健康状况及服务利用情况。
Drug Alcohol Rev. 2016 Mar;35(2):223-31. doi: 10.1111/dar.12266. Epub 2015 Oct 26.
9
Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.澳大利亚酒精及其他药物治疗服务中的戒烟护理提供情况:一项关于工作人员自我报告做法的横断面调查。
J Subst Abuse Treat. 2017 Jun;77:101-106. doi: 10.1016/j.jsat.2017.04.003. Epub 2017 Apr 7.
10
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.验证澳大利亚治疗结果概况在大麻依赖患者中的应用。
Drug Alcohol Rev. 2020 May;39(4):356-364. doi: 10.1111/dar.13050. Epub 2020 Mar 4.

引用本文的文献

1
The Role of Social Support and Belonging in Predicting Recovery from Problem Gambling.社会支持和归属感在预测赌博问题康复中的作用。
J Gambl Stud. 2024 Jun;40(2):775-792. doi: 10.1007/s10899-023-10225-y. Epub 2023 Jun 7.
2
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019.2016-2019 年澳大利亚新南威尔士州进入公共酒精和其他药物服务机构的报告安非他命类物质使用的客户的健康和社会特征。
Drug Alcohol Rev. 2023 Feb;42(2):389-400. doi: 10.1111/dar.13588. Epub 2022 Dec 16.
3
Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences.
数字干预措施以拯救阿片类药物危机期间和 SARS COVID-19 大流行期间的生命:对澳大利亚和加拿大经验的范围综述。
Front Public Health. 2022 Jul 12;10:900733. doi: 10.3389/fpubh.2022.900733. eCollection 2022.
4
COVID-19 Lockdown and Consumption Patterns among Substance Use Disorder Outpatients: A Multicentre Study.COVID-19 封锁期间物质使用障碍门诊患者的消费模式:一项多中心研究。
Eur Addict Res. 2022;28(4):243-254. doi: 10.1159/000521425. Epub 2022 Jan 17.
5
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia.澳大利亚悉尼东南部在 COVID-19 大流行期间阿片类激动剂治疗和患者结局。
Drug Alcohol Rev. 2022 Jul;41(5):1009-1019. doi: 10.1111/dar.13382. Epub 2021 Sep 14.
6
Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic.在 2019 冠状病毒病大流行期间维持阿片类药物使用障碍的治疗和预防计划。
Curr Opin Psychiatry. 2021 Jul 1;34(4):369-375. doi: 10.1097/YCO.0000000000000708.
7
Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.退伍军人事务部参与实施倡议以增强阿片类药物使用障碍药物获取途径的医疗机构应对 2019 年冠状病毒的反应。
Subst Abus. 2020;41(4):413-418. doi: 10.1080/08897077.2020.1809609. Epub 2020 Sep 16.
8
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review.新冠疫情时代的成瘾问题:当前证据、未来展望——全面综述。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070. doi: 10.1016/j.pnpbp.2020.110070. Epub 2020 Aug 12.